Physician

Vishak Johny John, M.D.

According to 2025 Medicare claims, Vishak John, M.D. (NPI: 1255515623) practices ophthalmology in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is VISTAR EYE CENTER, INC (NPI: 1457323545; TIN: 540853078) and primary practice location at 24019-3813.

John's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,227 traditional Medicare patients, billed 102,874 HCPCS/CPT codes, and received $5,111,279 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 482 prescription claims across 192 beneficiaries totaling $15,665 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 61 records totaling $40,296. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $229,763 to $5,111,279. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,182 and ending at $15,665. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.1M2015 Medicare payment: $229,763 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $283,958 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $308,624 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,474,145 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,902,800 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,922,956 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,071,298 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,173,033 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,377,831 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,111,279 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154632,239$229,763
20165953,234$283,958
20176303,143$308,624
20181,04210,505$2,474,145
20191,19917,174$3,902,800
20201,12115,572$3,922,956
20211,15916,388$4,071,298
20221,18521,690$4,173,033
20231,24161,137$4,377,831
20241,227102,874$5,111,279

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$26K2015 Drug cost: $10,182 (USD; Tot_Drug_Cst)2016 Drug cost: $18,388 (USD; Tot_Drug_Cst)2017 Drug cost: $26,302 (USD; Tot_Drug_Cst)2018 Drug cost: $23,915 (USD; Tot_Drug_Cst)2019 Drug cost: $18,981 (USD; Tot_Drug_Cst)2020 Drug cost: $20,301 (USD; Tot_Drug_Cst)2021 Drug cost: $24,479 (USD; Tot_Drug_Cst)2022 Drug cost: $19,258 (USD; Tot_Drug_Cst)2023 Drug cost: $18,528 (USD; Tot_Drug_Cst)2024 Drug cost: $15,665 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201571158$10,182
201689237$18,388
201787275$26,302
2018161464$23,915
2019164380$18,981
2020142316$20,301
2021194460$24,479
2022180464$19,258
2023185476$18,528
2024192482$15,665

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2381,610$657
67028Injection of drug into eye6142,258$92
92014Established patient complete exam of visual system1,1062,318$82
J2777Injection, faricimab-svoa, 0.1 mg30484,480$27
92134Imaging of retina1,1773,343$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1437,714$7,512
Ketorolac TromethamineKetorolac Tromethamine581,723$765
OfloxacinOfloxacin771,592$765
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat412,663$734
Brimonidine TartrateBrimonidine Tartrate191,135$403

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.61$40,296Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vishak Johny John, M.D.?

Tedicare shows public-source Medicare data for Vishak Johny John, M.D. (NPI 1255515623), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vishak Johny John, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vishak Johny John, M.D.?

Vishak Johny John, M.D. is linked to VISTAR EYE CENTER, INC (billing NPI 1457323545) in the available physician profile data.

Does Vishak Johny John, M.D. have Open Payments data?

Vishak Johny John, M.D. has 61 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.